Last reviewed · How we verify
Patients treated with Esketamine
Patients treated with Esketamine is a Small molecule drug developed by Neuronetics. It is currently in Phase 2 development. Also known as: spravato.
At a glance
| Generic name | Patients treated with Esketamine |
|---|---|
| Also known as | spravato |
| Sponsor | Neuronetics |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder (PHASE2)
- Phenomenological Explorations of the Esketamine-Induced Transient Dissociative State (NA)
- PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study (PHASE3)
- Mitochondrial Function After Ketamine
- The Efficacy and Safety of Short Term S-ketamine Infusion as an Adjunctive Therapy in Patients With Fibromyalgia (NA)
- Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity Surgery (NA)
- Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression (PHASE4)
- Comparison of Esketamine Nasal Spray vs.Aripiprazole in Treat.Resistant Major Depressive Disorder in Elderly Patients (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Patients treated with Esketamine CI brief — competitive landscape report
- Patients treated with Esketamine updates RSS · CI watch RSS
- Neuronetics portfolio CI
Frequently asked questions about Patients treated with Esketamine
What is Patients treated with Esketamine?
Patients treated with Esketamine is a Small molecule drug developed by Neuronetics.
Who makes Patients treated with Esketamine?
Patients treated with Esketamine is developed by Neuronetics (see full Neuronetics pipeline at /company/neuronetics).
Is Patients treated with Esketamine also known as anything else?
Patients treated with Esketamine is also known as spravato.
What development phase is Patients treated with Esketamine in?
Patients treated with Esketamine is in Phase 2.
Related
- Manufacturer: Neuronetics — full pipeline
- Also known as: spravato
- Compare: Patients treated with Esketamine vs similar drugs
- Pricing: Patients treated with Esketamine cost, discount & access